Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mario Heles"'
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S723- (2023)
Externí odkaz:
https://doaj.org/article/4114d8d59fee4e168e2fb48dcfe372f2
Publikováno v:
Journal of Neuroinflammation, Vol 18, Iss 1, Pp 1-11 (2021)
Abstract Background Opioid analgesics remain widely used for pain treatment despite the related serious side effects. Some of those, such as opioid tolerance and opioid-induced hyperalgesia may be at least partially due to modulation of opioid recept
Externí odkaz:
https://doaj.org/article/283da2c846314e67b4b0e0c8da04c39f
Autor:
Pavel Adamek, Mario Heles, Anirban Bhattacharyya, Monica Pontearso, Jakub Slepicka, Jiri Palecek
Publikováno v:
J Neurosci
The development of painful paclitaxel-induced peripheral neuropathy (PIPN) represents a major dose-limiting side effect of paclitaxel chemotherapy. Here we report a promising effect of duvelisib (Copiktra), a novel FDA-approved PI3Kδ/γ isoform-spec
Publikováno v:
Journal of neuroinflammation, Vol. 18, no.1, p. 279 (2021)
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 18, Iss 1, Pp 1-11 (2021)
Journal of Neuroinflammation
Journal of Neuroinflammation, Vol 18, Iss 1, Pp 1-11 (2021)
Background Opioid analgesics remain widely used for pain treatment despite the related serious side effects. Some of those, such as opioid tolerance and opioid-induced hyperalgesia may be at least partially due to modulation of opioid receptors (OR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5f35c8dc085bd7a24db4e7045cf0b53
https://hdl.handle.net/2078.1/270613
https://hdl.handle.net/2078.1/270613
Publikováno v:
Neuropharmacology. 146
Paclitaxel chemotherapy treatment often leads to neuropathic pain resistant to available analgesic treatments. Recently spinal Toll-like receptor 4 (TLR4) and the transient receptor potential cation channel subfamily V member 1 (TRPV1) were identifie
Publikováno v:
IBRO Reports. 6:S294